Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2022 - 02 - 08 save search
CNH Industrial 2021 Fourth Quarter and Full Year Results
Published: 2022-02-08 (Crawled : 23:00) - globenewswire.com
CNHI | News | $12.31 -0.73% 0.0% 6.9M
|
Producer Manufacturing
|
| O: -0.47%
H: 0.0%
C: 0.0%
trial results
Ocuphire Completes Enrollment in MIRA-3 Pivotal Phase 3 Clinical Trial for Nyxol® in RM and Announces Two Upcoming Medical Conference Presentations
Published: 2022-02-08 (Crawled : 19:00) - biospace.com/
OCUP | $1.66 -0.6% -0.6% 230K
|
Health Technology
|
| O: -0.34%
H: 8.47%
C: 8.47%
nyxol trial conference presentation phase 3 enroll
Global Industrial Robotics Market to Surpass US$ 69.1 Mn by end of 2027, Says Coherent Market Insights
Published: 2022-02-08 (Crawled : 19:00) - prnewswire.com
FANUF | $29.08 -7.69% 390
|
Producer Manufacturing
|
| O: 1.48%
H: 3.92%
C: 3.87%
FANUY | $13.93 -2.11% 210K
|
Manufacturing
|
| O: 1.27%
H: 0.75%
C: 0.7%
DNZOY | $18.47 0.08% 47K
|
Manufacturing
|
| O: 2.93%
H: 0.58%
C: 0.58%
FARO | $18.7 2.07% 2.03% 170K
|
Electronic Technology
|
| O: 1.02%
H: 1.28%
C: 1.08%
trial
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
Published: 2022-02-08 (Crawled : 17:00) - biospace.com/
MYMD | $2.54 0.8% 0.79% 18K
|
Manufacturing
|
| O: 0.23%
H: 1.16%
C: -5.35%
health phase 2 als trial positive
Karyopharm Announces Phase 3 SIENDO Study Meets Primary Endpoint with Statistically Significant Increase in Progression-Free Survival in Patients with Advanced or Recurrent Endometrial Cancer
Published: 2022-02-08 (Crawled : 13:00) - prnewswire.com
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -12.31%
H: 5.26%
C: -4.21%
trial cancer phase 3
Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome
Published: 2022-02-08 (Crawled : 12:00) - globenewswire.com
BMRA | $0.7459 -1.86% -1.89% 35K
|
Health Technology
|
| O: -0.71%
H: 2.14%
C: 0.95%
infoods treatment trial food topline results positive topline syndros
Iveric Bio Announces New Post-Hoc Analyses of Zimura® from GATHER1 Clinical Trial to Be Presented at Angiogenesis, Exudation, and Degeneration 2022
Published: 2022-02-07 (Crawled : 00:00) - biospace.com/
ISEE | $39.95 0.38% 0.38% 0
|
Health Technology
|
| O: 3.53%
H: 0.0%
C: 0.0%
zimura ces trial
BioRestorative Therapies Announces it has Initiated its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease – Site Selection Underway
Published: 2022-02-07 (Crawled : 00:00) - biospace.com/
BRTX | $1.39 -3.47% -3.6% 160K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 1.76%
C: -3.02%
phase 2 trial disease initiated therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.